BBIO - BridgeBio Pharma, Inc.

📈 Is growth accelerating? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Revenue Growth YoY (%)	66.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+735%)	2521.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+31415%)	4318.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+53875%)	4999.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+62398%)	-44.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-659%)	237.1% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2863%)	-33.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-515%)	32.1% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+301%)	11461.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+143174%)	-6.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-184%)	1110.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+13779%)	-97.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1322%)	7.8% Fair ↑ Fair Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: At sector avg	-85.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1169%)	-85.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1170%)	36.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+356%)	266.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3233%)	10462.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+130679%)	-71.2% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-989%)	—	—	—	-69.6% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-970%)	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	4.5% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	30.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-10.5% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-143.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-340.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-47.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	20.4% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	60.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	78.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-4.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-16.1% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-1300.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	9.8% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	89.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	1.8% Caution ↑ Caution Improving Year-over-year change in net income	—	-12.6% Weak ↑ Weak Improving Year-over-year change in net income	-143.2% Weak ↑ Weak Improving Year-over-year change in net income	-369.0% Weak ↓ Weak Declining Year-over-year change in net income	—	8.5% Fair ↓ Fair Declining Year-over-year change in net income	53.0% Excellent ↑ Excellent Improving Year-over-year change in net income	74.7% Excellent ↑ Excellent Improving Year-over-year change in net income	—	-28.0% Weak ↑ Weak Improving Year-over-year change in net income	-6179.9% Weak ↓ Weak Declining Year-over-year change in net income	29.1% Excellent ↓ Excellent Declining Year-over-year change in net income	—	12.9% Fair ↓ Fair Declining Year-over-year change in net income	97.5% Excellent ↑ Excellent Improving Year-over-year change in net income	-17.7% Weak ↓ Weak Declining Year-over-year change in net income	—	-23.7% Weak ↓ Weak Declining Year-over-year change in net income	25.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-64.4% Weak ↑ Weak Improving Year-over-year change in net income	—	-114.6% Weak ↓ Weak Declining Year-over-year change in net income	-83.2% Weak ↓ Weak Declining Year-over-year change in net income	-49.9% Weak Weak Year-over-year change in net income	—	-44.2% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—
FCF Growth YoY (%)	3.3% Caution Caution Year-over-year change in free cash flow	—	—	—	15.0% Fair Fair Year-over-year change in free cash flow	—	—	—	-30.3% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	374.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	335.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	609.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	14.5% Good ↓ Good Declining Compound annual revenue growth over 3 years	309.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-23.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	5.2% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	-65.8% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	670.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	142.7% Excellent Excellent Compound annual revenue growth over 3 years	-20.5% Weak Weak Compound annual revenue growth over 3 years	—	—	—	-76.7% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	234.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	317.2% Excellent Excellent Compound annual revenue growth over 5 years	71.5% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	-36.6% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Operating Margin (%) (%)	-54.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-463%)	-90.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-703%)	-120.3% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-902%)	-121.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-910%)	-89.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-697%)	—	—	—	0.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-99%)	—	—	—	—	—	—	-108.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-825%)	—	—	—	-174.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1260%)	—	—	—	—	—	—	-203.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1460%)	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	—	0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.8% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	-0.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-85.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-814%)	—	-153.2% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1377%)	-166.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1485%)	-145.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1312%)	—	—	—	-17.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-243%)	—	—	—	—	—	—	-3.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-129%)	—	—	—	-188.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1675%)	—	—	—	—	—	—	-226.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1990%)	—	—	—	—	—	—	—
FCF Margin (%) (%)	-101.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-36.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-91.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-73.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-170.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	-104.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	-174.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	1.18x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.60x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.44x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.17x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	—	6.09x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	—	1.01x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.80x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.92x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	—	1.02x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.92x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Return on Invested Capital (%)	-22.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	175.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-193.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	7.6% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	5.0% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	15.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	19.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	21.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-0.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	—	16.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	12.5% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	12.6% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	—	9.0% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	6.2% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	22.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	18.4% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	43.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	-17.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	—	-8.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-33.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-20.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—
Return on Capital (%) (%)	-7.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-24.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-28.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	0.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-24.1% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-29.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-17.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-21.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-19.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-15.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-10.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-8.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	7.3% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-51%)	—	9.6% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-36%)	10.3% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-31%)	10.3% Fair → Fair Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-31%)	—	13.4% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-11%)	6.9% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-54%)	3.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-77%)	—	14.9% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	11.8% Fair → Fair Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-21%)	11.6% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-22%)	—	12.3% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-18%)	0.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-98%)	19.3% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+29%)	—	21.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+44%)	—	43.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+189%)	—	—	—	-27.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-282%)	—	-13.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-188%)	-45.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-404%)	-27.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-284%)	—	—	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Debt to Equity (x)	-1.16x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-294%)	-0.96x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-260%)	-1.04x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-273%)	0.00x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	-0.35x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-159%)	-0.40x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-166%)	-0.41x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-169%)	—	-0.37x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-161%)	-0.32x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-154%)	-0.36x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-159%)	—	—	—	-0.42x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-170%)	—	-0.14x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-123%)	—	-0.23x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-138%)	—	—	—	0.24x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-60%)	0.23x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-61%)	0.16x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-73%)	—	—	0.17x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-71%)	—	—	—	—
Interest Coverage (x)	-5.22x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-7.12x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-11.58x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10.88x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-17.25x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-22.33x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-7.65x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	0.01x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-17.26x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-7.77x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-7.09x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6.27x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-15.13x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-6.51x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3.95x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.54x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10.94x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-13.51x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-8.67x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-17.20x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-11.63x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10.97x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-11.58x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-25.56x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-25.81x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-35.71x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-38.15x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-35.86x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$1.77B	$1.44B	$1.36B	$-748.95M	$-540.60M	$-681.10M	$169.90M	$27.49M	$-40.51M	$-375.94M	$-63.49M	$138.06M	$28.40M	$-376.69M	$-483.24M	$-470.10M	$62.56M	$-393.77M	$-77.21M	$-378.42M	$-380.41M	$-356.08M	$-366.97M	$-540.92M	$-664.63M	$-268.40M	$-338.96M	$-293.80M	$-373.03M	$-381.58M	$-211.72M	—	$-92.00M	—
Debt / EBITDA (x)	-25.32x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-14.53x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-13.96x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-2.27x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.48x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	224.20x Weak ↑ Weak Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-2.80x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-3.02x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-3.50x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	-2.53x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.69x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.54x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	-0.90x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-1.38x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Revenue per Share (USD)	$1.00	—	$0.63	$0.58	$0.61	—	$0.01	$0.01	$1.18	—	$0.03	$0.01	$0.01	—	$0.00	$0.50	—	—	—	$0.37	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.84	$-0.99	$-0.95	$-0.95	$-0.88	$-1.42	$-0.86	$-0.39	$-0.20	$-0.96	$-1.08	$-0.98	$-0.92	$-0.92	$-0.93	$-0.07	—	$-1.02	—	$-0.66	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-1.01	—	$-0.57	$-0.43	$-1.05	—	—	—	$-1.23	—	—	—	$-0.95	—	—	—	—	—	—	$-0.64	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-11.64	$-10.71	$-10.03	$-9.35	$-8.68	$-7.72	$-6.51	$-5.81	$-5.61	—	$-6.93	$-8.44	$-7.64	—	$-7.62	$-6.92	$-7.05	—	$-5.05	—	$-2.65	—	—	—	$3.14	$3.30	$3.92	—	—	$3.42	—	—	—	—
Tangible Book Value per Share (USD)	$-11.78	$-10.86	$-10.18	$-9.51	$-8.83	$-7.85	$-6.64	$-5.95	$-5.75	—	$-7.09	$-8.61	$-7.81	—	$-7.82	$-7.12	$-7.25	—	$-5.37	—	$-2.65	—	—	—	$3.14	$3.30	$3.92	—	—	$3.42	—	—	—	—
Basic Weighted Avg Shares (shares)	194.79M	—	191.85M	190.52M	190.15M	—	188.51M	187.59M	178.71M	—	163.31M	160.54M	152.65M	—	147.94M	146.68M	—	—	—	146.75M	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Working Capital (USD)	$424.93M	$509.78M	$622.78M	$736.42M	$543.07M	$566.29M	$305.36M	$481.87M	$641.95M	—	$481.61M	$322.76M	$456.11M	—	$523.02M	$630.12M	$612.77M	—	$543.89M	—	$850.38M	—	—	—	$860.04M	$508.24M	$518.30M	—	—	$412.65M	—	—	—	—
LT Debt (USD)	$2.65B	$2.01B	$2.01B	$0.00	$0.00	—	$436.22M	$435.45M	$434.72M	—	$441.72M	$440.50M	$435.76M	—	—	—	$434.11M	—	$103.14M	—	$90.76M	—	—	—	$92.42M	$95.37M	$75.02M	—	—	$54.51M	—	—	—	—
Total Equity (USD)	$-2.28B	$-2.09B	$-1.93B	$-1.79B	$-1.65B	$-1.47B	$-1.23B	$-1.09B	$-1.05B	—	$-1.21B	$-1.36B	$-1.23B	—	$-1.14B	$-1.03B	$-1.04B	—	$-743.40M	—	$-395.29M	—	—	—	$380.71M	$408.45M	$459.76M	$162.93M	$252.14M	$314.88M	—	$85.85M	$85.85M	$14.89M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Sales/Revenue/Turnover (USD)	$194.51M	$154.18M	$120.70M	$110.56M	$116.63M	$5.88M	$2.73M	$2.17M	$211.12M	$1.75M	$4.09M	$1.64M	$1.83M	$1.87M	$338.00K	$73.75M	$1.69M	$12.89M	$2.34M	$54.02M	$462.00K	$122.00K	$8.13M	—	—	—	$26.74M	—	—	—	—	—	—	—
Depreciation Expense (USD)	$1.19M	$1.44M	$1.40M	$1.32M	$1.28M	$1.37M	—	—	$1.60M	$1.58M	—	—	$1.63M	$1.66M	—	—	$1.88M	$1.53M	—	$3.49M	—	$435.00K	$-1.01M	—	—	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-166.56M	—	$-184.94M	$-183.76M	$-169.61M	—	$-164.25M	$-75.54M	$-36.16M	—	$-179.49M	$-160.70M	$-142.73M	—	$-140.19M	$-2.56M	$-201.33M	—	$-161.02M	$-102.07M	$-171.08M	—	$-130.17M	$-136.21M	$-104.08M	—	$-60.66M	$-74.33M	$-69.44M	—	$-42.08M	—	—	—
Operating Cash Flow (USD)	$-197.28M	$-56.42M	$-109.57M	$-80.68M	$-199.24M	$-195.33M	—	—	$-219.54M	$-124.82M	—	—	$-144.32M	$-93.24M	—	—	$-160.63M	$-133.90M	—	$-91.71M	$-150.76M	$-96.26M	$-131.68M	$-87.85M	$-83.92M	—	—	$-68.25M	$-59.14M	—	—	—	—	—

BridgeBio Pharma, Inc.

Analytical Summary

34-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BBIO with peers